Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/2011
10/05/2011CN102209731A A heparan sulphate which binds bmp2
10/05/2011CN102209529A Method for delivering a pharmaceutical composition to patient in need thereof
10/05/2011CN102206277A Antibodies that bind human interleukin-18 and methods of making and using
10/05/2011CN102206267A Molecular structure and application of tumor necrosis factor receptor 1 proligand assembly domain glycocluster
10/05/2011CN102205112A BMP composition for synergistic induction of ossification differentiation, and application thereof
10/05/2011CN102205109A Chinese medicinal composition for treating rheumatism and application thereof
10/05/2011CN102205100A Chinese medicinal composition for treating femoral head necrosis
10/05/2011CN102205097A Fire treatment Chinese native medicine and western medicine liniment and preparation method thereof
10/05/2011CN102205091A Pharmaceutical composition for treating pain syndrome or arthralgia syndrome and preparation method and application thereof
10/05/2011CN102205083A Xanthine oxidase inhibitor for treating gout and preparation method thereof
10/05/2011CN102205070A Medicament for treating rheumatoid diseases and preparation method thereof
10/05/2011CN102205062A Traditional Chinese medicine formula for coaptation and preparation method thereof
10/05/2011CN102205056A Medicinal liquor for treating senile lumbocrural arthralgia
10/05/2011CN102205047A Traditional Chinese medicine composition for treating ankylosing spondylitis
10/05/2011CN102205020A Traditional Chinese medicine for treating traumatic injury
10/05/2011CN102205008A Traditional Chinese medicine for treating cervical and lumbar hyperosteogeny
10/05/2011CN102205006A External medicament for treating osteomyelitis and preparation method thereof
10/05/2011CN102204996A Medicament for treating traumatic injury
10/05/2011CN102204994A Chinese medicinal preparation for treating osteoarthritis and preparation method thereof
10/05/2011CN102204988A Medicine for treating bovine osteomalacia
10/05/2011CN102204954A Zideng tablet and preparation method thereof
10/05/2011CN102204943A Extraction method of teasel root total saponins
10/05/2011CN102204932A Chinese medicinal preparation for treating rickets and osteoporosis and preparation method thereof
10/05/2011CN102204923A Medicinal composition for treating osteoporosis
10/05/2011CN102204922A Solid preparation of sodium fosinopril and hydrochlorothiazide medicinal composition
10/05/2011CN102204903A Application of peperomin E and peperomin B compounds to medicament for suppressing angiogenesis
10/05/2011CN102204764A Making method of pill pillow
10/05/2011CN101919946B Plaster for treating bone fracture
10/05/2011CN101912577B Medicament for treating rheumatism and rheumatoid disease and preparation process
10/05/2011CN101889967B Shampoo or hair conditioner additive and method for preparing same
10/05/2011CN101874864B Chinese traditional medicament for treating cervical vertigo diseases
10/05/2011CN101829313B Footbath effervescent tablet for improving rheumatic arthritis
10/05/2011CN101703649B Chinese patent medicament for treating bone traumatism and preparation process thereof
10/05/2011CN101585866B Polypeptide for regulating activity of FGFR3 and screening method and application thereof
10/05/2011CN101554390B Medicated wine for curing scapulohumeral periarthritis
10/05/2011CN101548950B Tripterine nanometer lipid injection and method for preparing same
10/05/2011CN101486992B Mesenchyma stem cell for inhibiting osteoclast generation, as well as preparation method and application thereof
10/05/2011CN101417095B Medicine for treating arthrodynia
10/05/2011CN101327287B Method for preparing Liaoyuanqili ultramicro powder
10/05/2011CN101301392B Chinese medicine for treating systemic lupus erythematosus and preparation thereof
10/05/2011CN101259194B Combined medicaments for treating rheumatism
10/05/2011CN101184484B Ligustilide ramification for treating inflammatory disorders
10/04/2011US8030517 CCR9 inhibitors and methods of use thereof
10/04/2011US8030487 2-amino—5-substituted pyrimidine inhibitors
10/04/2011US8030296 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
10/04/2011US8030275 Methods for treating obesity using fibroblast growth factor-like polypeptides
10/04/2011US8029796 Therapeutic anti-cytomegalovirus compounds
10/04/2011US8029793 Anticancer agents; rheumatic diseases; osteoporosis; antiinflammatory agents; cloning genes
10/04/2011CA2669481C Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf.alpha. levels
10/04/2011CA2494536C A 12-membered ring macrolide active substance
10/04/2011CA2478099C Inhibitors
09/2011
09/29/2011WO2011120013A2 Vista regulatory t cell mediator protein, vista binding agents and use thereof
09/29/2011WO2011119622A1 DIASTEREOMERS OF 2-METHYLENE-19-NOR-22-METHYL-1α,25- DIHYDROXYVITAMIN D3
09/29/2011WO2011119610A2 (20S)-2-METHYLENE-19-NOR-22-DIMETHYL-1α,25- DIHYDROXYVITAMIN D3 AND (20R)-2-METHYLENE-19-NOR-22- DIMETHYL-1α,25-HYDROXYVITAMIN D3
09/29/2011WO2011118954A9 Method for differentiating cartilage cells, bone cells, nerve cells or fat cells from human inferior turbinate mesenchymal stromal cells
09/29/2011WO2011118954A2 Method for differentiating cartilage cells, bone cells, nerve cells or fat cells from human inferior turbinate mesenchymal stromal cells
09/29/2011WO2011118795A1 Composition for treatment of damaged part
09/29/2011WO2011116527A1 Anti human rankl monoclonal antibodies and uses thereof
09/29/2011WO2011061744A3 Novel arylated camphenes, processes for their preparation and uses thereof
09/29/2011WO2011049338A3 Natural nanocream, and method for producing same
09/29/2011WO2011047093A3 Stem cells for musculoskeletal tissue repair
09/29/2011WO2011044452A3 Methods and compositions for amelioration of autoimmune disease using fusion proteins of anti-dendritic cell receptor antibody to peptide sequences
09/29/2011US20110239311 Agonists of NR2F6 For Immunosupression
09/29/2011US20110238186 Preparation of regenerative tissue scaffolds
09/29/2011US20110237783 Hydrazonopyrazole derivatives and their use as therapeutics
09/29/2011US20110237659 Chromenone derivatives as trpv3 antagonists
09/29/2011US20110237650 Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf
09/29/2011US20110237645 USE OF RNAi TECHNOLOGY TO INHIBIT ASIC3
09/29/2011US20110237631 Selective Glycosidase Inhibitors and Uses Thereof
09/29/2011US20110237625 SUBSTITUTED PHENOXY THIAZOLIDINEDIONES AS ESTROGEN RELATED RECEPTOR-á MODULATORS
09/29/2011US20110237624 Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents
09/29/2011US20110237617 Thieno[2,3-c] isoquinolines for use as inhibitors of parp
09/29/2011US20110237601 Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists
09/29/2011US20110237596 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
09/29/2011US20110237586 Biaryl compositions and methods for modulating a kinase cascade
09/29/2011US20110237583 2, 5-diamino-substituted pyrido [4, 3-d] pyrimidines as autotaxin inhibitors against cancer
09/29/2011US20110237573 N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators
09/29/2011US20110237557 Diastereomers of 2-methylene-19-nor-22-methyl-1alpha,25-dihydroxyvitamin d3
09/29/2011US20110237556 (20S)-2-METHYLENE-19-NOR-22-DIMETHYL-1alpha,25-DIHYDROXYVITAMIN D3 AND (20R)-2-METHYLENE-19-NOR-22-DIMETHYL-1alpha,25-HYDROXYVITAMIN D3
09/29/2011US20110237550 5-azaindole bisphosphonates
09/29/2011US20110237546 Method for treating a mammal by administration of a compound having the ability to release co
09/29/2011US20110237538 Treatment of lysosomal storage disorders and other proteostatic diseases
09/29/2011US20110237527 Sglt-2 inhibitors, methods of making them, and uses thereof
09/29/2011US20110237521 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease
09/29/2011US20110237514 PHARMACEUTICAL COMPOSITION FOR TREATING BONE DISEASES WHICH COMPRISES PROTEIN COMPRISING Frizzled1, Frizzled2 OR Frizzled7 EXTRACELLULAR CYSTEINE-RICH DOMAIN
09/29/2011US20110237511 EP4 Receptor Agonist, Compositions and Methods Thereof
09/29/2011US20110237506 Protein stabilization formulations
09/29/2011US20110237498 Soluble polypeptides for use in treating autoimmune and inflammatory disorders
09/29/2011US20110237497 Compositions of a v-atpase inhibitor in combination with a glucocorticoid receptor ligand and methods of use
09/29/2011US20110237495 Functional metabolomics coupled microfluidic chemotaxis device and identification of novel cell mediators
09/29/2011US20110236994 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
09/29/2011US20110236510 Pregnane glycoside compositions and caralluma extract products and uses thereof
09/29/2011US20110236501 Injectable dual delivery allograph bone/polymer composite for treatment of open fractures
09/29/2011US20110236479 Direct compression formulation and process
09/29/2011US20110236461 Methods for stimulating chondrogenesis utilizing a potassium channel inhibitor
09/29/2011US20110236435 ENHANCED BONE CELLS GROWTH AND PROLIFERATION ON TiO2 NANOTUBULAR SUBSTRATES TREATED BY RADIO-FREQUENCY PLASMA DISCHARGE
09/29/2011US20110236401 Compositions and methods for modulating lymphocyte activity
09/29/2011US20110236390 IL-17A Antagonists
09/29/2011US20110236384 Direct drug delivery system based on thermally responsive biopolymers
09/29/2011US20110236367 Rat cathespin dipeptidyl peptidase i (dppi): crystal structure and its uses